Human Molecular Genetics Group, Institute of Molecular and Cell Biology, University of Tartu, Riia 23, 51010 Tartu, Estonia.
Mol Cell Endocrinol. 2012 May 15;355(1):180-7. doi: 10.1016/j.mce.2012.02.009. Epub 2012 Feb 22.
The human GH/CSH cluster consisting of one pituitary-expressed (GH1) and four placenta-expressed loci has been implicated in maternal metabolic adaptation to pregnancy, regulation of intrauterine and postnatal growth. We investigated how the mRNA expression profile of placental GH2, CSH1 and CSH2 genes and their alternative transcripts correlates with maternal pre-eclampsia (PE) and/or gestational diabetes mellitus (GD). The expression of studied genes in PE placentas (n=17) compared to controls (n=17) exhibited a trend for reduced transcript levels. The alternative transcripts retaining intron 4, GH2-2 and CSH1-2 showed significantly reduced expression in PE cases without growth restriction (P=0.007, P=0.008, respectively). In maternal GD (n=23), a tendency of differential expression was detected only for the GH2 gene and in pregnancies with large-for-gestational-age newborns. Our results, together with those reported by others, are consistent with a pleiotropic effect of placental hGH/CSH genes at the maternal-fetal interface relating to the regulation of fetal growth and the risk of affected maternal metabolism.
人类 GH/CSH 簇由一个垂体表达(GH1)和四个胎盘表达的基因座组成,与母体代谢适应妊娠、调节宫内和产后生长有关。我们研究了胎盘 GH2、CSH1 和 CSH2 基因及其选择性转录本的 mRNA 表达谱与母体子痫前期 (PE) 和/或妊娠糖尿病 (GD) 的相关性。与对照组 (n=17) 相比,PE 胎盘 (n=17) 中研究基因的表达显示转录本水平降低的趋势。保留内含子 4 的选择性转录本 GH2-2 和 CSH1-2 在无生长受限的 PE 病例中表达明显降低 (P=0.007,P=0.008)。在母体 GD (n=23) 中,仅 GH2 基因和巨大儿的妊娠中检测到差异表达的趋势。我们的结果与其他人报告的结果一致,表明胎盘 hGH/CSH 基因在母体-胎儿界面具有多效性效应,与胎儿生长的调节和受影响的母体代谢的风险有关。